Skip to main navigation Skip to search Skip to main content

Response to First-Line Ritonavir-Boosted Protease Inhibitors (PI/r)-Based Regimens in HIV Positive Patients Presenting to Care with Low CD4 Counts: Data from the Icona Foundation Cohort

  • Antonella d'Arminio Monforte
  • , Alessandro Cozzi Lepri
  • , Franco Maggiolo
  • , Giuliano Rizzardini
  • , Paolo Emilio Manconi
  • , Nicola Gianotti
  • , Tiziana Quirino
  • , Carmela Pinnetti
  • , Stefano Rusconi
  • , Andrea De Luca
  • , Andrea Antinori
  • , Icona Foundation Study cohort including as Steering Committee members M. Andreoni
  • , A. Ammassari
  • , A. Antinori
  • , C. Balotta
  • , A. Bandera
  • , P. Bonfanti
  • , S. Bonora
  • , M. Borderi
  • , Andrea CALCAGNO
  • L. Calza, MR Capobianchi, A. Castagna, F. Ceccherini Silberstein, A. Cingolani, P. Cinque, A. Cozzi Lepri, A. d’Arminio Monforte, A. De Luca, A. Di Biagio, E. Girardi, N. Gianotti, A. Gori, G. Guaraldi, G. Lapadula, M. Lichtner, S. Lo Caputo, G. Madeddu, F. Maggiolo, G. Marchetti, S. Marcotullio, L. Monno, C. Mussini, S. Nozza, M. Puoti, E. Quiros Roldan, R. Rossotti, S. Rusconi, MM Santoro, A. Saracino, M. Zaccarelli

Research output: Contribution to journalArticlepeer-review

Abstract

There are no data comparing the response to PI/r-based regimens in people presenting for care with low CD4 counts or AIDS (LC).
Original languageEnglish
Pages (from-to)1-14
Number of pages14
JournalPLoS ONE
Volume11
Issue number6
DOIs
Publication statusPublished - 2016

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

  1. SDG 3 - Good Health and Well-being
    SDG 3 Good Health and Well-being

Fingerprint

Dive into the research topics of 'Response to First-Line Ritonavir-Boosted Protease Inhibitors (PI/r)-Based Regimens in HIV Positive Patients Presenting to Care with Low CD4 Counts: Data from the Icona Foundation Cohort'. Together they form a unique fingerprint.

Cite this